Suchergebnisse

Many substance abusers are at risk for HIV due to their drug using and sexual behaviors. HIV interventions developed early on for substance abusers did not account for gender differences. Women's risk for HIV around the world makes them more vulnerable than men, yet their circumstances are different and adaptations to interventions are needed. The Women's CoOp, considered a best-evidence intervention, has been adapted with several groups of noninjecting women in South Africa and with injecting drug-using women in Russia. To reach vulnerable women in diverse settings to test interventions to reduce their risk, researchers also need to mentor the next generation of scientists to help stem the feminization of HIV among substance abusers.

In the United States, there are more than 1,200 methadone maintenance treatment programs, with an estimated staff of 20,000, serving more than 200,000 patients annually. This book offers insights into: the effectiveness of methadone; the characteristics of successful methadone treatment programs; and regulation and accreditation issues

The authors examine the common assumption that AIDS/HIV outreach prevention programs and similar programs in methadone treatment compete for the same population by comparing injecting drug users (IDUs) reached by each intervention in four communities. Similar results across sites reinforced the conclusions that, compared to IDUs entering methadone treatment, the IDUs contacted in outreach were more likely to be male, black, and young; to start injecting drugs when they were older, have shorter histories of injecting risk, and currently inject drugs less often than daily; to inject infrequently only opiates and frequently inject only cocaine; and to have not been in formal treatment ever or in the past six months.